Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02153970 · ClinicalTrials.gov registry record
Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy
A clinical trial of Cerebral Palsy and Neuromuscular Disease, sponsored by National Institute of Nursing Research (NINR).
- Completed
- Registry status
- 137
- Enrollment target
- 1
- Study location
NCT02153970 is a study of Cerebral Palsy and Neuromuscular Disease that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 137 participants, below the 228-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02153970, a study of Cerebral Palsy and Neuromuscular Disease, has completed, sponsored by National Institute of Nursing Research (NINR).
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Neuromuscular diseases (NMDs) do not have cures. But future treatments will try to improve the health-related quality of life (HRQoL) in people with NMD. Computer questionnaires can help test HRQoL in people with NMD. They could help clinicians and researchers know how people with NMD and their caregivers are doing. They could also help show if treatments are making a difference. Researchers want to make sure two of these questionnaires PROMIS (Patient Reported Outcomes Measurement Information System) and Neuro-QOL (Quality of Life in Neurological Disorders) work the same way every time. They also want to make sure the questionnaires test the same things every time. Objective: \- To make sure the PROMIS and Neuro-QOL questionnaires are valid. Eligibility: \- Children age 8 17 who have NMD. Also, caregivers of children age 5 17 who have NMD. Design: * Participants will complete the PROMIS and Neuro-QOL questionnaires on a computer. The caregiver and child versions are not the same. * Participants will complete the questionnaires at the beginning of the study. It will take about 15 20 minutes. They will complete the questionnaires again after 2 4 weeks. They may receive phone or email reminders. * Participants will complete the questionnaires at the NIH outpatient clinic and/or on their own device. At NIH, they will use a computer or tablet.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2014-05-31 |
| Est. Completion | 2019-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02153970
The ClinicalTrials.gov registry entry for NCT02153970 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (40% lower). The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.
NCT02153970 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02153970 about?
NCT02153970 is a clinical study titled "Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy". Background: \- Neuromuscular diseases (NMDs) do not have cures. But future treatments will try to improve the health-related quality of life (HRQoL) in people with NMD. Computer questionnaires can help test HRQoL in people with NMD. They could help clinicians and researchers know how people with NM...
What is the current status of trial NCT02153970?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2014-05-31. Estimated completion is 2019-06-12.
What conditions does trial NCT02153970 study?
This clinical trial studies the following conditions: Cerebral Palsy, Neuromuscular Disease.
Who is sponsoring clinical trial NCT02153970?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02153970 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.